Effect of supplementation in treatment of Coronary Heart Disease
Phase 3
- Conditions
- Coronary Heart Disease.Ischaemic heart disease (chronic) NOSI25.9
- Registration Number
- IRCT201407015623N22
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Subjects aged 40-85 years
Diagnosed with type 2 diabetes and coronary heart disease
Exclusion Criteria
Smokers
Consuming selenium or antioxidant supplements within the past 3 months
Having an acute myocardial infarction within the past 3 months
Having cardiac surgery within the past 3 months
A major renal or liver failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method